European Patent Office

T 2900/18 (Treatment of glomerulonephritis/R-PHARM) of 23.06.2022

European Case Law Identifier
ECLI:EP:BA:2022:T290018.20220623
Date of decision
23 June 2022
Case number
T 2900/18
Online on
26 September 2022
Petition for review of
-
Application number
12174216.7
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Method for the treatment of glomerulonephritis
Applicant name
R-Pharm International, LLC
Opponent name
Ablynx N.V.
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 54
Keywords
Novelty - (no)
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.